Purine Antimetabolite class drugs

4 results
  • azathioprine

    (Azathioprine)
    AvKARE
    Azathioprine tablets are indicated for preventing rejection in renal transplants and managing active rheumatoid arthritis to reduce symptoms. It may be used alongside certain medications, but combined use with DMARDs has not been studied. Patient survival outcomes in transplants vary based on several factors.
  • azathioprine

    (Azathioprine)
    Amneal Pharmaceuticals NY LLC
    Azathioprine tablets are indicated to prevent rejection in renal homotransplantation and to manage active rheumatoid arthritis, reducing its signs and symptoms. Caution is advised when combining with other disease-modifying anti-rheumatic drugs, as their combined effects have not been studied.
  • cladribine

    (Cladribine)
    Hisun Pharmaceuticals USA, Inc.
    Cladribine Injection, USP is indicated for treating active Hairy Cell Leukemia, characterized by clinically significant anemia, neutropenia, thrombocytopenia, or related disease symptoms.
  • mavenclad

    (Cladribine)
    EMD Serono, Inc.
    MAVENCLAD is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including relapsing-remitting and active secondary progressive diseases. It is recommended for patients who have not adequately responded to or cannot tolerate other MS treatments. It is not recommended for clinically isolated syndrome (CIS).